Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort-Reference-Cited by-同舟云学术

Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

Published:2021-06-01 Issue:2 Volume:87 Page:806-817
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Pelchen-Matthews Annegret,Borges Álvaro H.,Reekie Joanne,Rasmussen Line D.,Wiese Lothar,Weber Jonathan,Pradier Christian,Degen Olaf,Paredes Roger,Tau Luba,Flamholc Leo,Gottfredsson Magnus,Kowalska Justyna,Jablonowska Elzbieta,Mozer-Lisewska Iwona,Radoi Roxana,Vasylyev Marta,Kuznetsova Anastasiia,Begovac Josip,Svedhem Veronica,Clark Andrew,Cozzi-Lepri Alessandro,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference30 articles.

1. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population;Wandeler;Curr Opin HIV AIDS.,2016

2. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies;Lancet HIV.,2017

3. Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study;Valantin;J Antimicrob Chemother.,2019

4. Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options;Bajema;AIDS.,2020

5. Fostemsavir in adults with multidrug-resistant HIV-1 infection;Kozal;N Engl J Med.,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry;Journal of Antimicrobial Chemotherapy;2024-07-15

2. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study;International Journal of Infectious Diseases;2024-06

3. Prevalence and clinical characteristics of people with HIV with limited treatment options in Japan: A Japanese claims data analysis;Journal of Infection and Chemotherapy;2024-06

4. Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study;Frontiers in Immunology;2024-05-28

5. Difficult-to-treat HIV in Sweden: a cross-sectional study;BMC Infectious Diseases;2024-03-18